Propel Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PROPEL PHARMA, and what generic and branded alternatives to PROPEL PHARMA drugs are available?
PROPEL PHARMA has one approved drug.
Drugs and US Patents for Propel Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Propel Pharma | VIGABATRIN | vigabatrin | FOR SOLUTION;ORAL | 213390-001 | Jul 29, 2021 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.